DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20182089

Study on the knowledge of pharmacovigilance among medical students

Lakshmi Deepika Patchva

Abstract


Background: Pharmacovigilance is the science and activity relating to the detection, assessment, understanding and prevention of adverse effects or any other drug–related problems. The ultimate aim of pharmacovigilance is to ensure safe and rational use of medicines, once they are released for general use in the society. The most important outcome of pharmacovigilance is the prevention of negative consequences of pharmacotherapy. So, the present study primary objective is to assess awareness of pharmacovigilance among medical students and to evaluate the knowledge of pharmacovigilance at Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinaoutpally (A.P.), a tertiary care teaching hospital.

Methods: A cross-sectional study will be carried out using a pretested questionnaire. The questionnaire will be designed to assess the knowledge regarding pharmacovigilance. The medical students (Final MBBS and Interns) were included in the study during the study period. Only the participants who will give their consent will be included in the study. Results will be calculated by proper statistical analysis.

Results: The current study was conducted in a medical college Dr. PSIMS and RF, which included a total of 180 medical students 75% final years, 25% interns. Most of them (89.8%) accepted that reporting ADR is necessary and pharmacovigilance should be taught in detail to healthcare professionals.

Conclusions: This study demonstrated that knowledge of pharmacovigilance among medical students is improving gradually, but unfortunately the actual practice of ADR reporting is still deficient among students.


Keywords


Adverse drug reactions, Knowledge, Medical students, Pharmacovigilance

Full Text:

PDF

References


Report of a WHO meeting, WHO technical report, International drug monitoring: The role of national centres, Ser. 1972;498:1-25.

Goyal M, Bansal M, Yadav S, Grover V. To Assess the Attitude, Knowledge and Practices of Medical Professionals About Adverse Drug Reactions and Their Reporting in a Teaching Hospital. Ind J of Cli Practic. 2013;24(3):281-4.

WHO. The importance of Pharmacovigilance. Geneva. 2002.

Patil A, Gurav YA, Thorat MB, Walsangikar SD. Survey of pharmacovigilance awareness among Healthcare professionals. Int J Pharma and Therap, 2014;4(3):31-4.

Jeya Ponmari S, Sivaraman M, Aruna T, Subhasree V. Knowledge and awareness of pharmacovigilance among various medical fraternities. Asian J of Pha and Toxicol. 2015;3(10):45-8.

World Health Organisation. Safety of Medicines: A guide to detecting and reporting adverse drug reactions. Geneva. 2002.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-36.

Gupta SKP, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011;3:1064-9.

Rajesh R, Vidyasagar S, Nandakumar K. Highly active antiretroviral therapy induced adverse drug reactions in Indian human immunodeficiency virus positive patients. Pharmacy Practice 2011 Jan -Mar;9(1):48-55.

Radhakrishnan R, Danturulu SV, Varma M. An Educational Intervention to assess Knowledge Attitude Practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital Int J of Pharm Tech Research. 2011;3(2):678-92.

Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharmaceutical Journal. 2018 Feb 6.

Kulmi M, Reddy P, Dhakre S, Shinde M, Goyal C. Knowledge, attitude and practices of pharmacovigilance among the postgraduate and undergraduate medical students in a tertiary care hospital in Central India. Int J of Bas & Cli Pharmac. 2017 Apr 24;6(5):1127-32.